Skip to main content
Erschienen in: Abdominal Radiology 2/2019

31.08.2018 | Pictorial essay

Imaging features related with prognosis of hepatocellular carcinoma

verfasst von: Chansik An, Myeong-Jin Kim

Erschienen in: Abdominal Radiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

We discuss various imaging features that have been reported to be associated with the prognosis of hepatocellular carcinoma (HCC) but not included in the current staging systems: findings related with microvascular invasion, tumor encapsulation, intratumoral fat, presence of satellite nodules, peritumoral hypointensity on hepatobiliary phase images of gadoxetic-acid enhanced MRI, restricted diffusion, and irregular rim-like hyperenhancement. Current evidence suggests that larger (> 2 cm) tumor size, presence of satellite nodules, presence of irregular rim-like hyperenhancement of a tumor, peritumoral parenchymal enhancement in the arterial phase, and peritumoral hypointensity observed on hepatobiliary phase images are independent imaging features to portend a worse prognosis in patients with hepatocellular carcinoma.
Literatur
1.
Zurück zum Zitat Sia D, Villanueva A, Friedman SL, Llovet JM (2017) Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152:745–761CrossRefPubMed Sia D, Villanueva A, Friedman SL, Llovet JM (2017) Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152:745–761CrossRefPubMed
2.
Zurück zum Zitat Kim H, Park YN (2014) Hepatocellular carcinomas expressing ‘stemness’-related markers: clinicopathological characteristics. Dig Dis 32:778–785CrossRefPubMed Kim H, Park YN (2014) Hepatocellular carcinomas expressing ‘stemness’-related markers: clinicopathological characteristics. Dig Dis 32:778–785CrossRefPubMed
3.
Zurück zum Zitat Walther Z, Jain D (2011) Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int 2011:403929PubMedPubMedCentral Walther Z, Jain D (2011) Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int 2011:403929PubMedPubMedCentral
4.
Zurück zum Zitat Elizabeth M, Brunt VP, Sempoux Christine, Theise ND (2015) Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepat Oncol 2:330–336 Elizabeth M, Brunt VP, Sempoux Christine, Theise ND (2015) Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepat Oncol 2:330–336
5.
Zurück zum Zitat Fan L, Mac MT, Frishberg DP, et al. (2010) Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. J Gastroenterol Hepatol 25:1556–1561CrossRefPubMed Fan L, Mac MT, Frishberg DP, et al. (2010) Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. J Gastroenterol Hepatol 25:1556–1561CrossRefPubMed
6.
Zurück zum Zitat Pirisi M, Leutner M, Pinato DJ, et al. (2010) Reliability and reproducibility of the edmondson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens. Arch Pathol Lab Med 134:1818–1822PubMed Pirisi M, Leutner M, Pinato DJ, et al. (2010) Reliability and reproducibility of the edmondson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens. Arch Pathol Lab Med 134:1818–1822PubMed
7.
Zurück zum Zitat Pawlik TM, Gleisner AL, Anders RA, et al. (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245:435–442CrossRefPubMedPubMedCentral Pawlik TM, Gleisner AL, Anders RA, et al. (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245:435–442CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRefPubMedPubMedCentral Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
10.
Zurück zum Zitat Kudo M, Matsui O, Izumi N, et al. (2014) Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update. Oncology 87(Suppl 1):7–21CrossRefPubMed Kudo M, Matsui O, Izumi N, et al. (2014) Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update. Oncology 87(Suppl 1):7–21CrossRefPubMed
11.
Zurück zum Zitat Lee JM, Park JW, Choi BI (2014) 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Dig Dis 32:764–777CrossRefPubMed Lee JM, Park JW, Choi BI (2014) 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Dig Dis 32:764–777CrossRefPubMed
12.
Zurück zum Zitat Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRefPubMedPubMedCentral Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150:835–853CrossRefPubMed Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150:835–853CrossRefPubMed
14.
Zurück zum Zitat Griffin N, Addley H, Sala E, et al. (2012) Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? Br J Radiol 85:736–744CrossRefPubMedPubMedCentral Griffin N, Addley H, Sala E, et al. (2012) Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? Br J Radiol 85:736–744CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 196:1083–1089CrossRefPubMed Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 196:1083–1089CrossRefPubMed
16.
Zurück zum Zitat Eguchi S, Takatsuki M, Hidaka M, et al. (2010) Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 34:1034–1038CrossRefPubMed Eguchi S, Takatsuki M, Hidaka M, et al. (2010) Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 34:1034–1038CrossRefPubMed
17.
Zurück zum Zitat Kaibori M, Ishizaki M, Matsui K, Kwon AH (2010) Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol 102:462–468CrossRefPubMed Kaibori M, Ishizaki M, Matsui K, Kwon AH (2010) Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol 102:462–468CrossRefPubMed
18.
Zurück zum Zitat McHugh PP, Gilbert J, Vera S, et al. (2010) Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB (Oxford) 12:56–61CrossRef McHugh PP, Gilbert J, Vera S, et al. (2010) Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB (Oxford) 12:56–61CrossRef
19.
Zurück zum Zitat Ariizumi S, Kitagawa K, Kotera Y, et al. (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18:575–585CrossRefPubMed Ariizumi S, Kitagawa K, Kotera Y, et al. (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18:575–585CrossRefPubMed
20.
Zurück zum Zitat Chou CT, Chen RC, Lin WC, et al. (2014) Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 203:W253–W259CrossRefPubMed Chou CT, Chen RC, Lin WC, et al. (2014) Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 203:W253–W259CrossRefPubMed
21.
Zurück zum Zitat Lim JH, Choi D, Park CK, Lee WJ, Lim HK (2006) Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 16:2326–2333CrossRefPubMed Lim JH, Choi D, Park CK, Lee WJ, Lim HK (2006) Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 16:2326–2333CrossRefPubMed
22.
Zurück zum Zitat Kim H, Park MS, Choi JY, et al. (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751CrossRefPubMed Kim H, Park MS, Choi JY, et al. (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751CrossRefPubMed
23.
Zurück zum Zitat Nishie A, Yoshimitsu K, Asayama Y, et al. (2008) Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 190:81–87CrossRefPubMed Nishie A, Yoshimitsu K, Asayama Y, et al. (2008) Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 190:81–87CrossRefPubMed
24.
Zurück zum Zitat Kim KA, Kim MJ, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634CrossRefPubMed Kim KA, Kim MJ, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634CrossRefPubMed
25.
Zurück zum Zitat Suh YJ, Kim MJ, Choi JY, Park MS, Kim KW (2012) Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging. Liver Transpl 18:1171–1178CrossRefPubMed Suh YJ, Kim MJ, Choi JY, Park MS, Kim KW (2012) Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging. Liver Transpl 18:1171–1178CrossRefPubMed
26.
Zurück zum Zitat Xu P, Zeng M, Liu K, et al. (2014) Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol 29:330–336CrossRefPubMed Xu P, Zeng M, Liu K, et al. (2014) Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol 29:330–336CrossRefPubMed
27.
Zurück zum Zitat Wang WT, Yang L, Yang ZX, et al. (2018) Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging. Radiology 286:571–580CrossRefPubMed Wang WT, Yang L, Yang ZX, et al. (2018) Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging. Radiology 286:571–580CrossRefPubMed
28.
Zurück zum Zitat Segal E, Sirlin CB, Ooi C, et al. (2007) Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol 25:675–680CrossRefPubMed Segal E, Sirlin CB, Ooi C, et al. (2007) Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol 25:675–680CrossRefPubMed
29.
Zurück zum Zitat Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN (2012) Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 81:3877–3882CrossRefPubMed Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN (2012) Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 81:3877–3882CrossRefPubMed
30.
Zurück zum Zitat Banerjee S, Wang DS, Kim HJ, et al. (2015) A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 62:792–800CrossRefPubMedPubMedCentral Banerjee S, Wang DS, Kim HJ, et al. (2015) A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 62:792–800CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Renzulli M, Brocchi S, Cucchetti A, et al. (2016) Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology 279:432–442CrossRefPubMed Renzulli M, Brocchi S, Cucchetti A, et al. (2016) Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology 279:432–442CrossRefPubMed
32.
Zurück zum Zitat Kim MJ, Lee M, Choi JY, Park YN (2012) Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging. Eur J Radiol 81:2507–2512CrossRefPubMed Kim MJ, Lee M, Choi JY, Park YN (2012) Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging. Eur J Radiol 81:2507–2512CrossRefPubMed
33.
Zurück zum Zitat An C, Choi GH, Lee HS, Kim MJ (2012) Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System. Invest Radiol 47:634–641CrossRefPubMed An C, Choi GH, Lee HS, Kim MJ (2012) Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System. Invest Radiol 47:634–641CrossRefPubMed
34.
Zurück zum Zitat Shindoh J, Andreou A, Aloia TA, et al. (2013) Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 20:1223–1229CrossRefPubMed Shindoh J, Andreou A, Aloia TA, et al. (2013) Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 20:1223–1229CrossRefPubMed
35.
Zurück zum Zitat American Joint Committee on Cancer (2017) AJCC cancer staging manual, 8th edn. New York: Springer American Joint Committee on Cancer (2017) AJCC cancer staging manual, 8th edn. New York: Springer
36.
Zurück zum Zitat Chen BB, Hsu CY, Yu CW, et al. (2016) Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy. Radiology 281:454–464CrossRefPubMed Chen BB, Hsu CY, Yu CW, et al. (2016) Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy. Radiology 281:454–464CrossRefPubMed
37.
Zurück zum Zitat Gao SY, Tang L, Cui Y, et al. (2016) Tumor angiogenesis-related parameters in multi-phase enhanced CT correlated with outcomes of hepatocellular carcinoma patients after radical hepatectomy. Eur J Surg Oncol 42:538–544CrossRefPubMed Gao SY, Tang L, Cui Y, et al. (2016) Tumor angiogenesis-related parameters in multi-phase enhanced CT correlated with outcomes of hepatocellular carcinoma patients after radical hepatectomy. Eur J Surg Oncol 42:538–544CrossRefPubMed
38.
Zurück zum Zitat Kawamura Y, Ikeda K, Seko Y, et al. (2011) Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation. AJR Am J Roentgenol 197:W665–W673CrossRefPubMed Kawamura Y, Ikeda K, Seko Y, et al. (2011) Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation. AJR Am J Roentgenol 197:W665–W673CrossRefPubMed
39.
Zurück zum Zitat Kierans AS, Leonardou P, Hayashi P, et al. (2010) MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging 28:790–796CrossRefPubMed Kierans AS, Leonardou P, Hayashi P, et al. (2010) MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging 28:790–796CrossRefPubMed
40.
Zurück zum Zitat Kitao A, Matsui O, Yoneda N, et al. (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265:780–789CrossRefPubMedPubMedCentral Kitao A, Matsui O, Yoneda N, et al. (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265:780–789CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Murakata A, Tanaka S, Mogushi K, et al. (2011) Gene expression signature of the gross morphology in hepatocellular carcinoma. Ann Surg 253:94–100CrossRefPubMed Murakata A, Tanaka S, Mogushi K, et al. (2011) Gene expression signature of the gross morphology in hepatocellular carcinoma. Ann Surg 253:94–100CrossRefPubMed
42.
Zurück zum Zitat Nakanishi M, Chuma M, Hige S, et al. (2012) Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol 19:1302–1309CrossRefPubMed Nakanishi M, Chuma M, Hige S, et al. (2012) Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol 19:1302–1309CrossRefPubMed
43.
Zurück zum Zitat Shimizu R, Tamai H, Mori Y, et al. (2016) The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma. Hepatol Int 10:328–339CrossRefPubMed Shimizu R, Tamai H, Mori Y, et al. (2016) The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma. Hepatol Int 10:328–339CrossRefPubMed
44.
Zurück zum Zitat Siripongsakun S, Lee JK, Raman SS, et al. (2012) MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol 199:1018–1025CrossRefPubMed Siripongsakun S, Lee JK, Raman SS, et al. (2012) MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol 199:1018–1025CrossRefPubMed
45.
Zurück zum Zitat Wu TH, Yu MC, Chen TC, et al. (2012) Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol 105:85–90CrossRefPubMed Wu TH, Yu MC, Chen TC, et al. (2012) Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol 105:85–90CrossRefPubMed
46.
Zurück zum Zitat Xu L, Peng ZW, Chen MS, et al. (2015) Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. J Hepatol 63:122–130CrossRefPubMed Xu L, Peng ZW, Chen MS, et al. (2015) Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. J Hepatol 63:122–130CrossRefPubMed
47.
Zurück zum Zitat Yamashita T, Kitao A, Matsui O, et al. (2014) Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 60:1674–1685CrossRefPubMedPubMedCentral Yamashita T, Kitao A, Matsui O, et al. (2014) Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 60:1674–1685CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Ng IO, Lai EC, Ng MM, Fan ST (1992) Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70:45–49CrossRefPubMed Ng IO, Lai EC, Ng MM, Fan ST (1992) Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70:45–49CrossRefPubMed
49.
Zurück zum Zitat Kang TW, Rhim H, Lee J, et al. (2016) Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. Eur Radiol 26:3437–3446CrossRefPubMed Kang TW, Rhim H, Lee J, et al. (2016) Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. Eur Radiol 26:3437–3446CrossRefPubMed
50.
Zurück zum Zitat Kim BK, Kim KA, An C, et al. (2015) Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization. Liver Int 35:1722–1730CrossRefPubMed Kim BK, Kim KA, An C, et al. (2015) Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization. Liver Int 35:1722–1730CrossRefPubMed
51.
Zurück zum Zitat Jeong HT, Kim MJ, Kim YE, et al. (2012) MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int 32:430–440PubMed Jeong HT, Kim MJ, Kim YE, et al. (2012) MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int 32:430–440PubMed
52.
Zurück zum Zitat Choi SY, Kim SH, Park CK, et al. (2018) Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma: a retrospective observational study. Radiology 286:897–908CrossRefPubMed Choi SY, Kim SH, Park CK, et al. (2018) Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma: a retrospective observational study. Radiology 286:897–908CrossRefPubMed
54.
Zurück zum Zitat An C, Kim DW, Park YN, et al. (2015) Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 276:433–443CrossRefPubMed An C, Kim DW, Park YN, et al. (2015) Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 276:433–443CrossRefPubMed
55.
Zurück zum Zitat Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534CrossRefPubMed Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534CrossRefPubMed
57.
Zurück zum Zitat Li M, Xin Y, Fu S, et al. (2016) Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas > 5 cm without extrahepatic metastases: an imaging-based retrospective study. Medicine 95:e2458CrossRefPubMedPubMedCentral Li M, Xin Y, Fu S, et al. (2016) Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas > 5 cm without extrahepatic metastases: an imaging-based retrospective study. Medicine 95:e2458CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Sakon M, Nagano H, Nakamori S, et al. (2002) Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 137:94–99CrossRefPubMed Sakon M, Nagano H, Nakamori S, et al. (2002) Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 137:94–99CrossRefPubMed
Metadaten
Titel
Imaging features related with prognosis of hepatocellular carcinoma
verfasst von
Chansik An
Myeong-Jin Kim
Publikationsdatum
31.08.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 2/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1758-y

Weitere Artikel der Ausgabe 2/2019

Abdominal Radiology 2/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.